Redhill biopharma ltd

Major-Pharmaceuticals

RDHL


21 Ha'arba'a Street
Tel Aviv , 6473921

Executive/
Director

Price

  • Last Close
  • $ 0.14
    $ +0 0 %
    Mar 22, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 1,586,892
  • Market Cap Full
  • $ 165.2M
  • Shares Outstanding
  • 1179.7M
    Dec 31, 2022
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 9.2% -4.9% -8.3% 0.2% 49.7% -5% -9.4% 3.5% - -
Q2 21% -11.3% -10.1% 72% -26.1% 4% -6% -67.4% - -
Q3 -26.7% 27.8% 25.4% -3% 11.4% 8% -33.4% -42.3% - -
Q4 -0.2% -24.7% -52.5% -37.9% -15.9% -20.9% -43.7% -72.1% - -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 55.7% 4.1% -38.3% - - - - - - - - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    13%-3%-19%-51%8%10%32%-68%-95%0%0%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.50 0.43 0.50 -0.5 -0.3 -0.5 -0.5 -13.04 20.00
Q2 0.66 0.60 0.60 -0.5 -0.4 -0.4 -0.6 -8 36.00
Q3 0.40 0.70 0.90 -0.4 -0.3 -0.5 -0.5 -24 -
Q4 0.50 0.70 0.50 -0.3 -0.4 -0.7 -18.72 -2.96 -
A 2.1 2.4 2.5 -1.7 -1.4 -2.1 -20.3 -48 56

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022
Mar - - - - -
Jun - - - - -
Sep - - - - -
Dec 283.7 352.7 384 526.8 1179.7

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 3 3.3 5.3 1 3
Fixed Asset Turnover 62 5.1 3.8 - -
Total Asset Turnover 0.4 0.5 0.4 0.1 0.1
Leverage
Debt Ratio - 0.9 1.1 - -
Debt – Equity Ratio - 9.3 5.8 - -
Interest Coverage -1.5 -4.8 -5.3 43 -
Equity multiplier - 1.9 1.2 - -